Zilovertamab Vedotin Alone or in Combination With Nemtabrutinib in Aggressive and Indolent B-Cell Malignancies: Phase 2waveLINE-006Study
Pier Luigi Zinzani,Jiri Mayer,Ohad Benjamini,Alejandro Berkovits,Ingrid Glimelius,Don Stevens,Arvind Chaudhry,Ahmet Muzaffer Demir,Ramon Garcia Sanz,Won Seog Kim,Li Fei,Janusz Halka,Ana Marin-Niebla,Muhit Ozcan,Ewa Paszkiewicz-Kozik,Armando Santoro,Ren Yixin,Uzor Ogbu,Patricia Marinello, Wojcieich Jurczak AMERICAN JOURNAL OF HEMATOLOGY（2023）
AI 理解论文
溯源树
样例
